Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 145 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, approximately 30,000 workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.

Please enable javascript to view.

MYL Last Trade




Daily High


Daily Low


Daily Volume


Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.

Upcoming Events

    No events are scheduled at this time. Please check back soon for updates

Past Events